Recent investment activity

KANDO id: 14395742

Corporate information

Company type

The corporate venture fund initiative of Canterbury Scientific Ltd.

Overview

CS Ventures is the corporate venture fund initiative of Canterbury Scientific Ltd., a leading OEM developer and supplier of high quality in vitro diagnostic controls and calibrators for diabetic and haemoglobinopathy applications worldwide. CS Ventures was established in 2019 to invest in promising IVD opportunities that align with Canterbury Scientific’s existing capabilities and to diversify into applications beyond diabetes mellitus.



Relation

Funding rounds

Top investment portfolio themes

Actual initial investment stage
Seed (1)

Investment activity status
Active investor

Selected investments

Displaying 1 - 1 of 1
Profile Country Date Funding
Vivodyne Inc Philadelphia-based biotech that tests its drug candidates on lab-grown human organs. Seed Initial investment

Current team

Past employees

Selected Products / Customers

Financials